SPAG5 and breast cancer: The expression of SPAG5 is increased in various tumor tissues, such as breast cancer, prostate cancer, lung cancer, hepatocellular carcinoma, gastric cancer, and cervical cancer, and upregulated SPAG5 is associated with poor prognosis in cancer patients [14–18].